COVID-19 Vaccine Hesitancy in Patients with Inflammatory Bowel Disease.

Authors:
Clarke K; Pelton M; Stuart A; Tinsley A; Dalessio S and 3 more

Journal:
Dig Dis Sci

Publication Year: 2022

DOI:
10.1007/s10620-021-07377-5

PMCID:
PMC8800396

PMID:
35092534

Journal Information

Full Title: Dig Dis Sci

Abbreviation: Dig Dis Sci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflicts of interestKC has reviewed research grants for Pfizer, Participated in Speakers Bureau for Janssen, ABBVie, Takeda and Pfizer. EW Participated in Speakers Bureau for Pfizer and ABBVie. AT Participated in Speakers Bureau for Pfizer. NB Participated in Speakers Bureau for Pfizer and AbbVie. Ethics approvalThis study was performed in line with the principles of the Declaration of Helsinki and approved by the Pennsylvania State University College of Medicine Institutional Review Board and carried out under protocol STUDY00013788. Consent to participateInformed consent was obtained from all individual participants included in the study. Conflicts of interest KC has reviewed research grants for Pfizer, Participated in Speakers Bureau for Janssen, ABBVie, Takeda and Pfizer. EW Participated in Speakers Bureau for Pfizer and ABBVie. AT Participated in Speakers Bureau for Pfizer. NB Participated in Speakers Bureau for Pfizer and AbbVie."

Evidence found in paper:

"Funding None to report."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025